retatrutide cons Pros and Cons: What Canadians Need to Know Tirzepatide vs Retatrutide: Comparing Weight

The phase 2 obesity trial for retatrutide enrolled a separate subgroup of people with obesity and NAFLD

The pivotal trials leading to FDA approval demonstrated reductions in visceral adipose tissue of approximately 15 to 20% over 26 weeks in HIV lipodystrophy patients, with continued reduction at 52 weeks

Open dialogue ensures your treatment plan is working for you and allows for any necessary adjustments to be made quickly, keeping you comfortable and on track with your wellness goals

However, an increase in gastrointestinal adverse events, diarrhea, hypoglycemia, nausea, neoplasm, treatment-emergent adverse events, pancreatic enzymes, diabetic retinopathy complications, and pancreatic cancer was observed to accompany the treatment using semaglutide